Category Archives: Press Releases

Precipio Announces 2021 Fourth Quarter And Year-End Shareholder Update Call

Conference Call to be held on Monday, April 4th, 2022 at 5:00 PM EST NEW [...]

Precipio Inc. Announces The Resignation Of Its Chief Financial Officer And Appointment Of Interim CFO

NEW HAVEN, CT, (Mar 21st, 2022) – Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), today announced that [...]

Precipio Releases Year-End 2021 Preliminary Unaudited Results And Outlook For 2022

NEW HAVEN, CT, (Feb 24th, 2022) – Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), today announced its [...]

New York State Approves Precipio’s HemeScreen For POL Clinical Use

New York Cancer & Blood POL will commence the use of HemeScreen in its laboratory [...]

Precipio Announces Q3-2021 And Year-End Shareholder Update Call

Conference Call to be held on Monday, November 15th, 2021 at 5:00 PM EST NEW [...]

American Oncology Network Partners With Precipio To Bring HemeScreen® Into AON’s Laboratory

HemeScreen Assays will enable AON to deliver rapid patient diagnostics for hematologic malignancies through advanced [...]

Precipio Reschedules Q2-2021 Shareholder Update Call

Due to a schedule conflict, the call is moved to Thursday August 26th at 5:00PM [...]

Precipio Announces Q2-2021 And Year-End Shareholder Update Call

Conference Call to be held on Monday, August 23rd, 2021 at 5:00 PM EST NEW [...]

Precipio Announces Preliminary Unaudited Q2-2021 Revenues Of $2.3M

Increase of 65% YoY, and 29% from Q1-2021 due to strong Pathology Growth and HemeScreen [...]

Precipio Terminates Its Equity Line

NEW HAVEN, CT, (Jun 15th, 2021) – Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), announces that as part [...]